fusion
splenocyt
aj
murin
strain
ns
myeloma
cell
produc
sever
hybridoma
among
eight
hybridoma
clone
clone
secret
kappa
appar
direct
nucleoprotein
virion
monoclon
antibodi
abl
neutral
tile
vitro
cytopath
effect
cultur
cell
detect
indirect
immunofluoresc
cultur
ac
cell
addit
confer
signific
protect
acut
diseas
inject
intraperiton
mice
inocul
mous
hepat
virus
mhv
member
coronaviru
famili
produc
variou
diseas
n
h
e
mous
anim
speci
exhibit
differ
tissu
tropism
pattern
infect
suscept
anim
virusinduc
diseas
appear
genet
control
differ
level
serolog
neutral
pattern
sever
mhv
complex
three
structur
protein
demonstr
variabl
degre
conserv
coronavirus
frequent
endem
laboratori
mous
coloni
neutral
monoclon
antibodi
recent
prepar
j
h
strain
brief
note
report
monoclonai
antibodi
appar
specif
nueleo
present
address
instituto
butantan
laboratoria
especi
de
immunologia
viral
paulo
brazil
protein
n
neutral
cytopath
activ
viru
cultur
cell
protect
suscept
mice
acut
diseas
result
infect
type
murin
hepat
viru
hybridoma
product
aj
mice
week
old
infect
intraperiton
vivo
propag
viru
two
week
later
mice
receiv
second
viru
challeng
intraperiton
anim
kill
day
later
spleen
remov
fusion
splenocyt
myeloma
cell
balbc
origin
perform
screen
rocheclon
antibodi
specif
antigen
done
enzymelink
immunosorb
elisa
dotimmunoblot
assay
two
success
preliminari
screen
elisa
hybridoma
posit
elisa
dotimmunoblot
assay
select
eight
clone
hybridoma
line
establish
two
clone
limit
dilut
two
hybridoma
one
clone
seven
clone
clone
character
test
reactiv
viru
protein
posit
elisa
wherea
posit
elisa
dot
immunoblot
test
kappa
subtyp
one
gave
workabl
amount
ascit
fluid
transplant
hybridoma
aj
x
balb
e
hybrid
mice
sinc
seven
subclon
seri
gave
similar
data
neutral
report
result
monoclon
antibodi
polypeptid
specif
monoclon
antibodi
determin
western
immunoblot
use
concentr
supernat
l
cell
figur
show
tlhe
react
protein
minor
band
show
monoelon
antibodi
gave
intens
reaction
lane
latter
antibodi
gave
similar
imunobtot
profil
strain
mhv
show
strong
crossreact
elisa
wherea
eprop
recogn
monoclonai
antibodi
appear
conserv
lost
data
shown
therefor
establish
monoelon
antibodi
like
specif
two
differ
epitop
structur
ix
protein
viral
specif
monoclon
antibodi
also
establish
indirect
immunofluores
chromatograph
purifi
immunoglobulin
ascit
fluid
use
reaction
live
yac
cell
express
antigen
live
infect
cell
detect
fitcconjug
rabbit
antimous
immuneglobulin
serum
mile
laboratori
inc
elkhart
ind
figur
show
ascit
fluid
react
surfac
yac
cell
membran
noninfect
cell
vivo
neutral
pertbrm
intraperiton
inject
mice
ml
asciti
fluid
challeng
describ
mice
surviv
acut
normal
lethal
diseas
recov
healthi
appear
within
week
ratio
surviv
mice
infect
mice
determin
day
infect
provid
signific
protect
inject
infect
tabl
protect
obtain
nonneutr
ascit
fluid
hybridoma
clone
irrelev
monoclon
antibodi
interest
look
ibr
histolog
evid
protect
conir
monoclonai
antibodi
suscept
nonneutr
monoclon
antibodi
mice
unrel
viru
monoclon
antibodi
mice
mice
anoth
group
mice
inject
ml
aseiti
fluid
challeng
five
mice
inject
similar
amount
irrelev
monoelon
antibodi
human
herp
p
e
viru
intraperiton
inocul
mice
sensit
infect
liver
result
rapidli
lethal
hepat
within
day
histolog
examin
brain
liver
remov
day
fix
histolog
fix
perfix
fisher
scientif
co
fair
lawn
nj
section
gm
stain
hematoxilin
eosin
time
two
mice
receiv
irrelev
monoclonm
antibodi
die
challeng
three
surviv
mice
multifo
necrot
hepat
evid
liver
surviv
mice
sacrifi
six
day
postinocul
numer
randomli
distribut
loci
present
hepatoeyt
undergon
eoagul
necrosi
mark
infiltr
mix
leukoeyt
fig
contrast
day
challeng
mice
receiv
monoelon
antibodi
small
scatter
lesion
observ
consist
mainli
mix
reaction
nuclear
cell
lesion
observ
brain
either
passiv
protect
infect
mice
fig
knowledg
first
monoclon
antibodi
report
specif
n
protein
confer
vivo
protect
furthermor
shown
react
epitop
express
surfac
infeet
yac
cell
contrast
monoclonm
antibodi
although
specif
n
protein
show
complement
mediat
neutral
vitro
protect
activ
vivo
react
infect
cell
plasma
membran
antin
protein
monoclon
antibodi
without
vitro
neutral
activ
could
confer
protect
mice
report
previous
hand
monoclon
antibodi
n
protein
h
v
j
h
like
monoelon
antibodi
protect
activ
lethal
dose
viru
assum
monoclon
antibodi
react
differ
epitop
would
also
explain
differ
pattern
crossrcaet
shown
b
e
l
obvious
small
number
monoclon
antibodi
seri
exhibit
differ
pattern
reaction
possibl
analys
viru
structur
relat
protect
mechan
done
mhv
howev
present
u
demonstr
least
one
epitop
n
protein
access
antibodi
surfac
infect
cell
yet
shown
mhv
b
u
shown
n
protein
influenza
viru
envisag
although
antin
protein
monoclonm
antibodi
prevent
adsorpt
viru
initi
first
cycl
replic
could
confer
protect
react
surfac
infect
cell
caus
antibodydepend
complement
cellmedi
cytolysi
shown
variou
viru
infect
